BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000848 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 20, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
44,980
Total Value
$3,727,250.87
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 18, 2026 | Sale | 1,900 | $81.15 | $154,183.86 | 276,407 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 18, 2026 | Sale | 17,279 | $82.21 | $1,420,513.50 | 259,128 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 18, 2026 | Sale | 14,602 | $82.99 | $1,211,852.10 | 244,526 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 18, 2026 | Sale | 1,199 | $83.77 | $100,444.07 | 243,327 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 19, 2026 | Sale | 8,100 | $83.86 | $679,256.28 | 507,586 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Aug 19, 2026 | Sale | 1,800 | $84.69 | $152,436.06 | 505,786 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Aug 19, 2026 | Sale | 100 | $85.65 | $8,565.00 | 505,686 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details |